The FDA has approved the use of pembrolizumab (Keytruda) for some previously untreated patients with a certain type of lung cancer, the drug’s owner Merck (NYSE: MRK) announced late Monday.
Our bodies are designed to fight disease, but we’re increasingly able to leverage its abilities further than ever. Eight-year-old Ava Christianson recently received a groundbreaking immunotherapy treatment for her lymphoblastic leukemia.
